Miguel Santiago Gonzalez-Mancera
5PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 12, 2024
5-Hydroxymethylcytosine (5-hmC) loss is a marker of malignancy in biliary neoplasms.Miguel S Gonzalez-Mancera, Andrew Siref, Kambiz Kosari
|Dec 02, 2021
Risk of malignancy associated with the diagnostic categories proposed by the Papanicolaou Society of Cytopathology for pancreaticobiliary specimens: An institutional experience.Miguel S Gonzalez-Mancera, Saman S Ahmadian, Carmen Gomez-Fernandez
|Apr 17, 2020
In Reply to: CD4+CD8+ Double-Positive T-Lymphocytes: PitfallsMiguel Santiago Gonzalez-Mancera, John Mario Gonzalez
|Jan 28, 2020
Double-positive T Lymphocytes Do Not Vary in Different Age Groups in Colombian Blood DonorsMiguel S. Gonzalez-Mancera, John Mario Gonzalez
|Oct 16, 2019
Percentages of CD4+CD8+ Double-positive T Lymphocytes in the Peripheral Blood of Adults from a Blood Bank in Bogotá, ColombiaMiguel S. Gonzalez-Mancera, Natalia I. Bolaños, Manuel Salamanca
Pageof 1
